Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Hallett David had 26,657 Recursion Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded Aug 17, 2026 · Filed Aug 18, 2026
On Aug 17, 2026, Hallett David (Chief Scientific Officer) had 26,657 Recursion Pharmaceuticals, Inc. shares withheld for tax at US$3.16 for US$84,236, leaving 1,043,837 shares. Filed Aug 18, 2026 (Form 4).
- Withheld for tax
- 26,657 shares
- Price
- US$3.16
- Value
- US$84,236
- Holding after
- 1,043,837 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Class A Common Stock | Shares withheld for tax | 26,657 | US$3.16 | 1,043,837 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Hallett David
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Hallett David · May 19, 2026
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026